🔬 Pharmidex: Scientific Excellence Meets Client-Centric Delivery
August 4, 2025
At
Pharmidex, we go beyond exceptional science we deliver an experience built on trust, flexibility and deep collaboration.
📍
Scientist-Led from Start to Finish
Your journey begins and ends with scientists, not sales teams. Our BD and Ops leads bring real scientific expertise to every conversation, ensuring smart, tailored study design and seamless execution.
🤝
Connected Teams, Coordinated Delivery
From DMPK and bioanalysis to in vivo pharmacology, our integrated teams ensure smooth handoffs, eliminating delays and duplication.
🧪
Agile, High-Quality Science
We adapt to evolving study needs across CNS, oncology, respiratory, autoimmune and rare diseases without compromising on quality. GLP and non-GLP studies are delivered on time, with transparency.
🧭
We’re Not Just a CRO, We’re Your Partner
We offer guidance on model selection, regulatory strategy, data interpretation, and more. Your success is our mission.
Let’s partner on your next breakthrough.
📧 Contact us today.
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
